XLO

Conviction 70HealthcareScan · Thu, Jun 25, 2026

XLO$8.83-2.00%

ResistanceSupportVol 14

Vol MA14 36.23K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Xilio Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.xiliotx.com ↗

Price8.83

Change-2.00%

Gap+0.00%

Rel volume1.69×

Avg volume31.44K

Avg $ vol265.5K

SMA 208.36

SMA 508.26

SMA 2003.38

Price vs 50+6.86%

Price vs 200+161.51%

MA stackbullish

50/200 cross—

Supertrendup · 7.55

RSI (14)61

MACD hist0.07

MACD crossbull · 5d

Stoch %K / %D74 / 78

ADX (14)18

+DI / −DI21 / 17

RSI divergence—

MACD divergenceBullish

ATR %+5.23%

ADR %5.47%

52w high9.01

52w low0.5101

From 52w high-2.00%

Above 52w low+1631.03%

New 52w highNo

SqueezeOff

Bollinger width19.15%

%B0.79

Donchian pos73.57%

Donchian high9.30

Donchian low7.53

AVWAP (52w high)8.94

vs AVWAP high-1.25%

AVWAP (52w low)5.52

vs AVWAP low+60.04%

OBV trendUp

Chaikin MF (20)0.03

Today vs 20d1.69×

Avg vol (14d)36.23K

Avg vol (20d)31.44K

Avg $ vol (20d)265.5K

Market cap51.06M

RS 3m (vs SPY)-4.61%

RS 6m (vs SPY)+1239.05%

RS line new highNo

Trend template7/8

Technical rank90.0

1 week+0.91%

1 month+5.75%

3 months+3.52%

6 months+1234.24%

1 year+1237.07%

YTD+1214.57%

P/E-1.46

P/B0.70

P/S1.17

P/FCF-9.27

EPS-4.19

Div yield—

ROE-48.30%

ROA-21.43%

Debt/Eq—

Current3.59

EV/EBITDA2.45

Gross margin—

Net margin-80.05%

Rev growth589.88%

EPS growth39.84%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-99.27M

Revenue12.65M

Net income-9.53M

Gross profit—

Free cash flow-5.51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out6.58M

Employees76

ListedFri, Oct 22, 2021

Free float30.47M

Float %45.1%

Short interest165.27K

Days to cover5.4d

Short volume65.5%

Squeeze score53 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction70 / 100

Pattern quality—

Tech rank90.0 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance9.15

Support7.47

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XLO

All disclosures →

No recent disclosed trades by Congress in XLO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XLO · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Blanchard Cheryl R Director · Stock Option (right to buy) · 2026-04-15	Grant	10K	$0	2026-04-15	2026-04-16

SEC filings

EDGAR filings in XLO · 1 recent

EDGAR →

8-K8-KFri, Jun 12, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.